Evolution of renal function after partial and full mechanical support for chronic heart failure

Evolution of renal function after partial and full mechanical support for chronic heart failure

Int J Artif Organs 2014; 37(5): 364 - 370


Article Subject: Cardiac assist and artificial heart



Steven Jacobs, Walter Droogne, Valerie Waelbers, Klaartje Van den Bossche, Hilde Bollen, Jef Geens, Filip Rega, Daniel Burkhoff, Bart Meyns

Corresponding author

  • Steven Jacobs
  • UZ Leuven
  • Herestraat 49
  • B - 3000 Leuven, Belgium



Recently a minimal invasive, partial support continuous flow left ventricular assist device (LVAD) became available for treatment of chronic heart failure. The aim of this study was to analyze whether partial support is capable of improving kidney function in end-stage heart failure.


We performed a single-center retrospective analysis of patients how received a full (n = 43) or partial support LVAD (n = 18) between 2007 and 2013. Patients on dialysis or in INTERMACS class I were excluded. Renal function was assessed until 3 months after the implantation. A calculated GFR less than 60 m/min was considered to be renal failure.


Creatinine level after LVAD implant decreased 23% in patients on full support (1.3 ± 0.4 mg/dl vs. 1.0 ± 0.3 mg/dl; p<0.001) and 24% in patients on partial support (1.6 ± 0.6 mg/dl vs. 1.2 ± 0.4 mg/dl; p = 0.17) within 3 months. In each group patients with a preoperative GFR less than 60 ml/min were selected. In this subgroup there was a 35% decrease in creatinine levels for patients on full support (1.7 ± 0.4 mg/dl vs. 1.1 ± 0.5 mg/dl; p<0.01) and a 32% decrease in patients on partial support (2 ± 0.4 mg/dl vs. 1.4 ± 0.3 mg/dl; p<0.05) at 3 months.


We observed a significant improvement in renal function in patients supported by full or partial support devices, even if the preoperative renal function was severly impaired. The use of diuretics decreased in both groups. In chronic heart failure patients with impaired renal function, partial support is sufficient to improve renal function significantly.

Article History


Financial Support: None.
Conflict of Interest: Bart Meyns receives research grants from CircuLite Inc., Saddlebrook, NJ, USA; Daniel Burkhoff is an employee of CircuLite Inc., Saddlebrook, NJ, USA.

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36.00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.



  • Cardiac Surgery, Catholic University Leuven, Leuven - Belgium
  • Cardiology, Catholic University Leuven, Leuven - Belgium
  • Columbia University, New York, New York - USA
  • CircuLite, Inc., Saddle Brook, New Jersey - USA

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.